Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice.
Inflammopharmacology
; 31(4): 1993-2005, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37155118
Full text:
1
Database:
MEDLINE
Main subject:
Atherosclerosis
/
NLR Family, Pyrin Domain-Containing 3 Protein
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Inflammopharmacology
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Type:
Article